William Plovanic
Stock Analyst at Canaccord Genuity
(4.16)
# 1,648
Out of 4,693 analysts
668
Total ratings
47.3%
Success rate
6%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRTC iRhythm Holdings | Maintained: Buy | $196 | $122.35 | +60.20% | 36 | Aug 27, 2026 | |
| TLSI TriSalus Life Sciences | Maintained: Buy | $7 | $5.17 | +35.40% | 22 | Aug 26, 2026 | |
| AORT Artivion | Maintained: Buy | $39 → $40 | $27.09 | +47.66% | 15 | Aug 18, 2026 | |
| BVS Bioventus | Maintained: Buy | $7 → $19 | $13.67 | +38.99% | 3 | Aug 17, 2026 | |
| CBLL CeriBell | Maintained: Buy | $25 → $26 | $24.58 | +5.78% | 15 | Aug 13, 2026 | |
| TMDX TransMedics Group | Maintained: Buy | $95 | $82.24 | +15.52% | 57 | Aug 12, 2026 | |
| ATRC AtriCure | Maintained: Buy | $55 | $48.92 | +12.43% | 38 | Aug 11, 2026 | |
| TNDM Tandem Diabetes Care | Maintained: Buy | $40 | $21.28 | +87.97% | 15 | Aug 11, 2026 | |
| PLSE Pulse Biosciences | Maintained: Buy | $32 → $43 | $52.09 | -17.45% | 3 | Aug 11, 2026 | |
| CVRX CVRx, Inc. | Maintained: Buy | $5 | $3.04 | +64.47% | 39 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $249 → $179 | $148.38 | +20.64% | 44 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $374 | $322.58 | +15.94% | 31 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $82 → $90 | $90.14 | -0.16% | 45 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $85 | $90.74 | -6.33% | 40 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $66 | $48.08 | +37.27% | 43 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 | $50.43 | -26.63% | 13 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $2.84 | +5.63% | 30 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $25 | $9.21 | n/a | 8 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $71 → $79 | $80.48 | n/a | 20 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $25 | $18.92 | n/a | 3 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $19 | $15.86 | n/a | 10 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $49.88 | n/a | 1 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $295 → $300 | $317.40 | n/a | 22 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $150 → $131 | $99.40 | n/a | 14 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $32 | $28.97 | n/a | 6 | Nov 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $20.53 | n/a | 1 | Nov 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $48 → $43 | $23.52 | n/a | 17 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $86 → $70 | $90.68 | n/a | 17 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $20 | $2.24 | n/a | 10 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.33 | n/a | 7 | Feb 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $4.52 | n/a | 11 | Jan 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $7.20 | n/a | 6 | Nov 5, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $22 | - | n/a | 7 | Jul 29, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0005 | n/a | 6 | Feb 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $73 → $63 | $80.16 | n/a | 7 | Jun 5, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $14 | $9.57 | n/a | 4 | Jul 31, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $9.43 | n/a | 1 | Sep 9, 2011 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $16.62 | n/a | 1 | Jun 28, 2011 |
iRhythm Holdings
Aug 27, 2026
Maintained: Buy
Price Target: $196
Current: $122.35
Upside: +60.20%
TriSalus Life Sciences
Aug 26, 2026
Maintained: Buy
Price Target: $7
Current: $5.17
Upside: +35.40%
Artivion
Aug 18, 2026
Maintained: Buy
Price Target: $39 → $40
Current: $27.09
Upside: +47.66%
Bioventus
Aug 17, 2026
Maintained: Buy
Price Target: $7 → $19
Current: $13.67
Upside: +38.99%
CeriBell
Aug 13, 2026
Maintained: Buy
Price Target: $25 → $26
Current: $24.58
Upside: +5.78%
TransMedics Group
Aug 12, 2026
Maintained: Buy
Price Target: $95
Current: $82.24
Upside: +15.52%
AtriCure
Aug 11, 2026
Maintained: Buy
Price Target: $55
Current: $48.92
Upside: +12.43%
Tandem Diabetes Care
Aug 11, 2026
Maintained: Buy
Price Target: $40
Current: $21.28
Upside: +87.97%
Pulse Biosciences
Aug 11, 2026
Maintained: Buy
Price Target: $32 → $43
Current: $52.09
Upside: -17.45%
CVRx, Inc.
Aug 11, 2026
Maintained: Buy
Price Target: $5
Current: $3.04
Upside: +64.47%
Aug 6, 2026
Maintained: Buy
Price Target: $249 → $179
Current: $148.38
Upside: +20.64%
Aug 4, 2026
Maintained: Hold
Price Target: $374
Current: $322.58
Upside: +15.94%
Aug 3, 2026
Reiterated: Buy
Price Target: $82 → $90
Current: $90.14
Upside: -0.16%
Aug 3, 2026
Maintained: Hold
Price Target: $85
Current: $90.74
Upside: -6.33%
Jul 30, 2026
Reiterated: Buy
Price Target: $70 → $66
Current: $48.08
Upside: +37.27%
Jun 29, 2026
Maintained: Buy
Price Target: $37
Current: $50.43
Upside: -26.63%
Apr 6, 2026
Maintained: Buy
Price Target: $3
Current: $2.84
Upside: +5.63%
Jan 22, 2024
Maintained: Buy
Price Target: $22 → $25
Current: $9.21
Upside: n/a
Jan 22, 2024
Maintained: Buy
Price Target: $71 → $79
Current: $80.48
Upside: n/a
Jan 22, 2024
Maintained: Buy
Price Target: $24 → $25
Current: $18.92
Upside: n/a
Dec 21, 2023
Maintained: Buy
Price Target: $17 → $19
Current: $15.86
Upside: n/a
Dec 21, 2023
Maintained: Buy
Price Target: $15
Current: $49.88
Upside: n/a
Dec 15, 2023
Maintained: Hold
Price Target: $295 → $300
Current: $317.40
Upside: n/a
Dec 15, 2023
Maintained: Hold
Price Target: $150 → $131
Current: $99.40
Upside: n/a
Nov 30, 2023
Maintained: Hold
Price Target: $32
Current: $28.97
Upside: n/a
Nov 7, 2023
Maintained: Buy
Price Target: $65
Current: $20.53
Upside: n/a
Sep 15, 2023
Maintained: Hold
Price Target: $48 → $43
Current: $23.52
Upside: n/a
Aug 28, 2023
Maintained: Hold
Price Target: $86 → $70
Current: $90.68
Upside: n/a
Feb 23, 2023
Maintained: Buy
Price Target: $16 → $20
Current: $2.24
Upside: n/a
Feb 2, 2016
Maintained: Buy
Price Target: $8
Current: $1.33
Upside: n/a
Jan 11, 2016
Reiterated: Buy
Price Target: $12
Current: $4.52
Upside: n/a
Nov 5, 2015
Maintained: Buy
Price Target: $16
Current: $7.20
Upside: n/a
Jul 29, 2015
Reiterated: Hold
Price Target: $25 → $22
Current: -
Upside: n/a
Feb 2, 2015
Reiterated: Hold
Price Target: n/a
Current: $0.0005
Upside: n/a
Jun 5, 2014
Maintained: Buy
Price Target: $73 → $63
Current: $80.16
Upside: n/a
Jul 31, 2013
Reiterated: Hold
Price Target: $17 → $14
Current: $9.57
Upside: n/a
Sep 9, 2011
Maintained: Buy
Price Target: $45
Current: $9.43
Upside: n/a
Jun 28, 2011
Reiterated: Buy
Price Target: n/a
Current: $16.62
Upside: n/a